These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
408 related articles for article (PubMed ID: 7852133)
1. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials. Rieke JW; Hafermann MD; Johnson JT; LeVeque FG; Iwamoto R; Steiger BW; Muscoplat C; Gallagher SC Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):661-9. PubMed ID: 7852133 [TBL] [Abstract][Full Text] [Related]
2. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. LeVeque FG; Montgomery M; Potter D; Zimmer MB; Rieke JW; Steiger BW; Gallagher SC; Muscoplat CC J Clin Oncol; 1993 Jun; 11(6):1124-31. PubMed ID: 8501499 [TBL] [Abstract][Full Text] [Related]
3. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia. Sangthawan D; Watthanaarpornchai S; Phungrassami T J Med Assoc Thai; 2001 Feb; 84(2):195-203. PubMed ID: 11336078 [TBL] [Abstract][Full Text] [Related]
4. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. Johnson JT; Ferretti GA; Nethery WJ; Valdez IH; Fox PC; Ng D; Muscoplat CC; Gallagher SC N Engl J Med; 1993 Aug; 329(6):390-5. PubMed ID: 8326972 [TBL] [Abstract][Full Text] [Related]
5. Effect of oral pilocarpine on post-irradiation xerostomia in head and neck cancer patients: a single-center, single-blind clinical trial. Chitapanarux I; Kamnerdsupaphon P; Tharavichitkul E; Sumitsawan Y; Sittitrai P; Pattarasakulchai T; Lorvidhaya V; Sukthomya V; Pukanhaphan N; Traisatit P J Med Assoc Thai; 2008 Sep; 91(9):1410-5. PubMed ID: 18843872 [TBL] [Abstract][Full Text] [Related]
6. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer. Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571 [TBL] [Abstract][Full Text] [Related]
7. A multicenter maintenance study of oral pilocarpine tablets for radiation-induced xerostomia. Jacobs CD; van der Pas M Oncology (Williston Park); 1996 Mar; 10(3 Suppl):16-20. PubMed ID: 8723429 [TBL] [Abstract][Full Text] [Related]
8. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study. Burlage FR; Roesink JM; Kampinga HH; Coppes RP; Terhaard C; Langendijk JA; van Luijk P; Stokman MA; Vissink A Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):14-22. PubMed ID: 17869018 [TBL] [Abstract][Full Text] [Related]
9. Oral pilocarpine: new preparation. Xerostomia after radiation therapy: moderately effective but costly. Prescrire Int; 2002 Aug; 11(60):99-101. PubMed ID: 12199276 [TBL] [Abstract][Full Text] [Related]
11. Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer. Chambers MS; Posner M; Jones CU; Biel MA; Hodge KM; Vitti R; Armstrong I; Yen C; Weber RS Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1102-9. PubMed ID: 17379432 [TBL] [Abstract][Full Text] [Related]
12. Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia. Wiseman LR; Faulds D Drugs; 1995 Jan; 49(1):143-55. PubMed ID: 7705213 [TBL] [Abstract][Full Text] [Related]
13. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome. Khurshudian AV Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025 [TBL] [Abstract][Full Text] [Related]
14. A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer. Warde P; O'Sullivan B; Aslanidis J; Kroll B; Lockwood G; Waldron J; Payne D; Bayley A; Ringash J; Kim J; Liu FF; Maxymiw W; Sprague S; Cummings BJ Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):9-13. PubMed ID: 12182969 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of pilocarpine lozenge for post-radiation xerostomia in patients with head and neck cancer. Taweechaisupapong S; Pesee M; Aromdee C; Laopaiboon M; Khunkitti W Aust Dent J; 2006 Dec; 51(4):333-7. PubMed ID: 17256309 [TBL] [Abstract][Full Text] [Related]
16. Pilocarpine for radiation-induced xerostomia in head and neck cancer. Hawthorne M; Sullivan K Int J Palliat Nurs; 2000 May; 6(5):228-32. PubMed ID: 12419994 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648 [TBL] [Abstract][Full Text] [Related]
18. Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia. Jha N; Seikaly H; Harris J; Williams D; Sultanem K; Hier M; Ghosh S; Black M; Butler J; Sutherland D; Kerr P; Barnaby P Head Neck; 2009 Feb; 31(2):234-43. PubMed ID: 19107948 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia. Witsell DL; Stinnett S; Chambers MS Head Neck; 2012 Aug; 34(8):1136-42. PubMed ID: 22231734 [TBL] [Abstract][Full Text] [Related]
20. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients. Scarantino C; LeVeque F; Swann RS; White R; Schulsinger A; Hodson DI; Meredith R; Foote R; Brachman D; Lee N J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]